banner add

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

from NYT > Health https://ift.tt/faK0nD4
via IFTTT

No comments

FDA Classifies Egg Recall as Class I for Highest Health Risk

Nearly 20 million eggs were recalled in July over salmonella concerns. The new classification signals a “reasonable probability” of “serious...

Theme images by PLAINVIEW. Powered by Blogger.